Matinas Biopharma Holdings Inc

ASE:MTNB   3:59:57 PM EDT
1.01
0.00 (0.00%)
4:23:38 PM EDT: $1.03 +0.02 (+1.98%)
Earnings Announcements

Matinas BioPharma Reports Third Quarter 2021 Financial Results And Operational Highlights

Published: 11/08/2021 11:42 GMT
Matinas Biopharma Holdings Inc (MTNB) - Matinas Biopharma Reports Third Quarter 2021 Financial Results and Operational Highlights.
Q3 Loss per Share $0.03.
Believes Cash on Hand is Sufficient to Fund Planned Operations Into 2024.
Q3 Earnings per Share View $-0.02 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.45 Million
Adjusted EPS is expected to be -$0.03

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.02

More details on our Analysts Page.